TY - JOUR T1 - Using deep learning algorithms to simultaneously identify right and left ventricular dysfunction from the electrocardiogram JF - medRxiv DO - 10.1101/2021.03.31.21254696 SP - 2021.03.31.21254696 AU - Akhil Vaid AU - Kipp W Johnson AU - Marcus A Badgeley AU - Sulaiman S Somani AU - Mesude Bicak AU - Isotta Landi AU - Adam Russak AU - Shan Zhao AU - Matthew Levin AU - Robert S Freeman AU - Alexander W Charney AU - Atul Kukar AU - Bette Kim AU - Tatyana Danilov AU - Stamatios Lerakis AU - Edgar Argulian AU - Jagat Narula AU - Girish N Nadkarni AU - Benjamin S Glicksberg Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/06/2021.03.31.21254696.abstract N2 - Background Rapid evaluation of left and right ventricular function using deep learning (DL) on electrocardiograms (ECG) can assist diagnostic workflow. However, DL tools to estimate right ventricular (RV) function do not exist, while ones to estimate left ventricular (LV) function are restricted to quantification of very low LV function only.Objectives This study sought to develop deep learning models capable of comprehensively quantifying left and right ventricular dysfunction from ECG data in a large, diverse population.Methods A multi-center study was conducted with data from five New York City hospitals; four for internal testing and one serving as external validation. We created novel DL models to classify Left Ventricular Ejection Fraction (LVEF) into categories derived from the latest universal definition of heart failure, estimate LVEF through regression, and predict a composite outcome of either RV systolic dysfunction or RV dilation.Results We obtained echocardiogram LVEF estimates for 147,636 patients paired to 715,890 ECGs. We used Natural Language Processing (NLP) to extract RV size and systolic function information from 404,502 echocardiogram reports paired to 761,510 ECGs for 148,227 patients.For LVEF classification in internal testing, Area Under Curve (AUC) at detection of LVEF<=40%, 40%<LVEF<=50%, and LVEF>50% was 0.94 (95% CI:0.94-0.94), 0.82 (0.81-0.83), and 0.89 (0.89-0.89) respectively. For external validation, these results were 0.94 (0.94-0.95), 0.73 (0.72-0.74) and 0.87 (0.87-0.88). For regression, the mean absolute error was 5.84% (5.82-5.85) for internal testing, and 6.14% (6.13-6.16) in external validation. For prediction of the composite RV outcome, AUC was 0.84 (0.84-0.84) in both internal testing and external validation.Conclusions DL on ECG data can be utilized to create inexpensive screening, diagnostic, and predictive tools for both LV/RV dysfunction. Such tools may bridge the applicability of ECGs and echocardiography, and enable prioritization of patients for further interventions for either sided failure progressing to biventricular disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the National Center for Advancing Translational Sciences, National Institutes of Health (U54 TR001433-05). This study has been approved by the institutional review board at the Icahn School of Medicine at Mount Sinai. The authors have no relationships relevant to the content of this paper to disclose.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study has been approved by the institutional review board at the Icahn School of Medicine at Mount Sinai.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData utilized for training models cannot be released due to privacy concerns. ER -